Human phospholipase inhibitor
US5663059A · kind A · utility
6Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 23, 1996 |
| Grant date | Sep 2, 1997 |
| Priority date | — |
| Expiry date | May 23, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a polynucleotide (gipl) the partial sequence for which was initially isolated from a THP-1 cDNA library and which identifies and encodes a novel human phospholipase inhibitor (GIPL). The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequence encoding GIPL.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.